To prepare and evaluate orodispersible tablet of anti-inflammatory drug
Daksh Institute of Pharmaceutical Sciences, Chhatarpur, M.P., India.
Research Article
World Journal of Biology Pharmacy and Health Sciences, 2022, 12(01), 165–173.
Article DOI: 10.30574/wjbphs.2022.12.1.0161
Publication history:
Received on 11 September 2022; revised on 15 October 2022; accepted on 18 October 2022
Abstract:
Oral drug delivery remains the preferred route for administration of various drugs. Recent developments in the technology have prompted scientists to develop orally disintegrating tablets (ODTs) with improved patient compliance and convenience. Orodispersible tablets are solid unit dosage forms, which disintegrate or dissolve rapidly in the mouth without chewing and water. Orodispersible tablets provide an advantage particularly for pediatric and geriatric populations who have difficulty in swallowing conventional tablets and capsules. This review describes the various formulation aspects, disintegrant employed and technologies developed for ODTs, along with various excipients, evaluation tests, marketed formulations, and drugs explored in this field.
Keywords:
Oral dosage form; Oral dispersible tablet; Anti-inflammatory drug
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0